PrP-targeting siRNA Safety & Mechanism Study
PrP-targeting siRNA Safety & Mechanism Study
Recruiting · NCT07444580 · Registry updated 2026-08-28Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| PrP-targeting siRNA Safety & Mechanism Study | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Creutzfeldt Jacob disease, Dyssomnias, Gerstmann-Straussler-Scheinker syndrome, Infections, Sleep Disorders, Intrinsic, brain disorder, central nervous system disorder, central nervous system infectious disorder, cognitive disorder, dementia, fatal familial insomnia, hereditary disease, inherited neurodegenerative disorder, insomnia, nervous system disorder, neurodegenerative disease, prion disease, psychiatric disorder, sleep-wake disorder | Recruiting | Phase 1 | 2026-08-28 | NCT07444580 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Broad Institute of MIT and Harvard | 12 |
| National Institute of Neurological Disorders and Stroke (NINDS) | 370 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Columbia University Medical center | New York | United States | 224 |
| Massachusetts General Hospital | Boston | United States | 1015 |
| Mayo Clinic | Rochester | United States | 664 |
| University Hospitals Cleveland Medical Center | Cleveland | United States | 234 |
| Vanderbilt University Medical Center | Nashville | United States | 427 |